Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus

Area of Science:

• Pulmonary Medicine
• Virology
• Immunology

Background:

• Pulmonary surfactant is crucial for airway patency.
• Respiratory Syncytial Virus (RSV) infection can impact lung function.

Purpose of the Study:

• To investigate the role of pulmonary surfactant dysfunction in Respiratory Syncytial Virus (RSV) infection using a mouse model.
• To determine if RSV infection leads to impaired surfactant function and identify potential inhibitory factors.

Main Methods:

• Mice were inoculated with varying doses of RSV.
• Bronchoalveolar lavage (BAL) was performed to collect lung fluids.
• Surfactant function was assessed using a capillary surfactometer.
• BAL fluid was analyzed for inflammatory cells, proteins, and phospholipids.
• Inhibitory effects of BAL fluid on calf lung surfactant extract were evaluated.

Main Results:

• RSV infection caused a dose-dependent disruption of pulmonary surfactant function.
• BAL fluid from RSV-infected mice inhibited normal surfactant function, indicating the presence of inhibitors.
• Protein concentrations in BAL fluid were elevated in RSV-infected mice and inversely correlated with surfactant function.
• Increased protein levels correlated with a higher percentage of inflammatory cells.

Conclusions:

• Pulmonary surfactant dysfunction is a significant factor in the pathophysiology of RSV infection.
• Inflammatory proteins in the airways likely inhibit surfactant function during RSV infection.
• These findings highlight a novel mechanism contributing to lung injury in RSV.